Clinical trials were recently conducted and proved promising for a Lyme Disease vaccine developed by science researchers at Stony Brook University. The vaccine proved to produce a large number of antibodies against all targeted species of Borrelia, which causes Lyme Disease in Europe and the United States. Baxter International S.A., who worked with Stony Brook University researchers to develop the vaccine, conducted the clinical trials.
Science Market Update
After receiving $2 million in philanthropic gifts in honor of Thomas Hartman, the Thomas Hartman Center for Parkinson’s Research in the Stony Brook University Department of Neurobiology and Behavior was dedicated in a ceremony on June 13th, 2013. Thomas Hartman was a much loved priest, television and radio personality, and believer in many causes who was diagnosed with Parkinson’s disease in 2004.
Lab suppliers marketing university lab equipment and hoping to increase scientific product sales may want to take a closer look at Stony Brook University’s latest research funding grants. Stony Brook University was recently awarded $2.45 million from the New York state government to fund programs are that have been designated as having “high need.” The government will be awarding $12 million to 36 SUNY colleges over the next three years.